ACell.com
About ACell.com
ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix (“ECM”) devices to repair and remodel damaged tissues and organs in a broad range of surgical procedures. ACell’s patented ECM devices are covered by multiple U.S. Food and Drug Administration (“FDA”) clearances and address important unmet clinical needs, providing safe, effective and economic therapeutic outcomes to the surgical community.